PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 75 filers reported holding PASSAGE BIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $150,191 | -38.6% | 228,254 | -12.2% | 0.00% | -100.0% |
| Q2 2023 | $244,601 | -11.6% | 259,854 | -10.1% | 0.00% | 0.0% |
| Q1 2023 | $276,704 | -43.4% | 288,926 | -18.5% | 0.00% | -50.0% |
| Q4 2022 | $489,104 | +1.5% | 354,423 | -8.1% | 0.00% | 0.0% |
| Q3 2022 | $482,000 | -47.6% | 385,810 | -0.9% | 0.00% | -33.3% |
| Q2 2022 | $919,000 | -42.2% | 389,497 | -24.1% | 0.00% | -40.0% |
| Q1 2022 | $1,591,000 | -41.6% | 513,241 | +19.7% | 0.01% | -16.7% |
| Q4 2021 | $2,722,000 | +32.9% | 428,600 | +108.4% | 0.01% | +20.0% |
| Q3 2021 | $2,048,000 | +73.3% | 205,640 | +130.3% | 0.01% | +66.7% |
| Q2 2021 | $1,182,000 | +372.8% | 89,304 | +524.0% | 0.00% | +200.0% |
| Q1 2021 | $250,000 | – | 14,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $49,399,000 | 20.45% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,185,869 | $11,811,000 | 9.97% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $24,879,000 | 7.18% |
| FRAZIER MANAGEMENT LLC | 5,009,219 | $49,892,000 | 3.99% |
| Orbimed Advisors | 6,962,899 | $69,350,000 | 0.76% |
| Boxer Capital, LLC | 1,928,315 | $19,206,000 | 0.67% |
| Vivo Capital, LLC | 539,263 | $5,371,000 | 0.24% |
| Logos Global Management LP | 125,010 | $1,245,000 | 0.09% |
| Weiss Multi-Strategy Advisers LLC | 336,034 | $3,347,000 | 0.07% |
| Virtus ETF Advisers LLC | 14,687 | $146,000 | 0.06% |